Press Release FeedGet the RSS feed
Menu

GlobeNewswire

Rocket Doctor AI Announces Global Company Town Hall to Showcase Q2 2026 Milestones and Strategic Vision

GlobeNewswire

Vancouver, BC, Sept. 09, 2026 -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”), a physician-built, AI-powered healthcare technology company focused on empowering doctors and expanding access to high-quality care, is pleased to announce that it will host a comprehensive Company Town Hall on Monday, September 14, 2026.

The virtual event will be co-led by Dr. Essam Hamza, CEO Rocket Doctor AI Inc. and Dr. William Cherniak Founder and CEO, Rocket Doctor Inc., who will provide a strategic retrospective overview of Rocket Doctor’s operational successes and key highlights in Q2 2026, and articulate the Company’s growth strategy for the United States and Canada for the remainder of 2026.

Event Details

  1. Libtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)Companies: Regeneron PharmaceuticalsLonger-term data reflecting nearly 4 years of follow-up show a further reduction in the risk of death from 14% to 37% for those initially treated with Libtayo, despite an 88% crossover from the placebo arm upon recurrence
  2. HealthcareKFSH Expands Virtual Care Pathways to Bring Specialized Follow-Up Closer to PatientsKing Faisal Specialist Hospital and Research Centre (KFSH) is expanding virtual and alternative care pathways at its Jeddah hospital, giving patients greater flexibility in how they access specialized services while reducing the need for unnecessary hospital visits.
  3. FinanceBioNTech und Bristol Myers Squibb präsentieren ermutigende Daten aus globaler Phase-2-Studie mit Pumitamig bei fortgeschrittenem nicht-kleinzelligem Lungenkrebs nach Progression der Erkrankung unter einer Immuntherapie und ChemotherapieCompanies: Bristol-Myers SquibbMAINZ, Deutschland und PRINCETON, USA, 25. Oktober 2026 – BioNTech SE (Nasdaq: BNTX, „BioNTech“) und Bristol Myers Squibb Company (NYSE: BMY, „BMS“) gaben heute erste Daten aus der globalen klinischen Phase-2-Studie ROSETTA Lung-107 (NCT06841055) bekannt. In der Studie wird der bispezifische PD-L1xVEGF-A-Immunmodulator-Kandidat Pumitamig (BNT327/BMS986545) in Kombination mit Docetaxel bei Patientinnen und Patienten mit metastasiertem nicht-kleinzelligem Lungenkrebs (non-small cell lung cancer, „NSCLC“) untersucht, deren Erkrankung während oder nach einer Erstlinienbehandlung mit Immuntherapie plus Chemotherapie fortgeschritten ist.
  4. FinanceBioNTech and Bristol Myers Squibb Report Encouraging Global Phase 2 Data for Pumitamig in Advanced NSCLC After Progression on Immunotherapy Plus ChemotherapyCompanies: Bristol-Myers SquibbMAINZ, Germany, and — BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Bristol Myers Squibb Company (NYSE: BMY, “BMS”) today announced first data from the global Phase 2 ROSETTA Lung-107 clinical trial (NCT06841055) evaluating pumitamig, an investigational PD-L1xVEGF-A bispecific immunomodulator (BNT327/BMS986545), in combination with docetaxel in patients with metastatic non-small cell lung cancer (“NSCLC”) whose disease progressed on or after first-line immunotherapy plus chemotherapy.
  5. Consumer electronicsRentomojo Launches Refrigerators From ₹459, Washing Machines From ₹414, Smart TVs From ₹689 and ACs From ₹1,802 a Month in Delhi for 2026, Setting Out What Each Appliance Costs to Rent Against BuyingA Fridge, Washing Machine and 32-Inch Smart TV Rent for About ₹1,642 a Month in Delhi Against About ₹47,000 to Buy; Rentomojo's Delhi Appliance Range Also Covers Microwaves From ₹264, Induction Cooktops From ₹195, Air Purifiers From ₹361 for the Winter Air Season, Air Coolers and Dishwashers, With Free Repairs, Replacement if Unrepairable and Free Relocation
  6. وسائل إعلام عالمية تختبر السيارة SOUEAST S08 DM: تجربة قيادة حقيقية على الطرقووهو، الصين, Oct. 25, 2026 -- وسائل إع اجتمع في 21 أكتوبر إعلاميون ومؤثرون (KOL)، وممثلون عن المستخدمين من أكثر من 10 دول ومناطق بمنطقة "موغانشان" في الصين، وذلك لحضور ‎2026 SOUEAST Global Technology Experience Day (فعالية SOUEAST العالمية لتجربة التكنولوجيا لعام 2026). ومن خلال تجارب القيادة، أُتيحت للمُشاركين فرصة اختبار السيارة SOUEAST S08 DM مباشرة، والتعرّف على قدرات ونقاط قوة نظامها الهجين C-DM في ظل ظروف متنوعة للقيادة على الطرق.